HALISTER: Novartis 1Q Core EPS Beats Estimates; Keeps FY16 Forecast

Novartis 1Q Core EPS Beats Estimates; Keeps FY16 Forecast

(Bloomberg) -- Co. still sees FY16 net sales and core oper. income broadly in line with prior yr at constant FX.
  • 1Q net sales: $11.6b vs est. $11.8b
  • 1Q core EPS: $1.17 vs est. $1.15
  • 1Q core oper. income (ebit): $3.26b vs est. $3.15b
  • 1Q core net income: $2.76b
  • Statement
  • NOTE: Yday, PREVIEW NOVARTIS 1Q: Gleevec Patent Expiry, Alcon, FX to Weigh
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
NOVN VX (Novartis AG)

To de-activate this alert, click here

UUID: 7947283